Aim Exploration Inc (AEXE): I also seen sdni fly in the same market...

JaMex · 2021-09-30T16:45:58.3000000Z

I also seen sdni fly in the same market from .02-.30! And others! U just Never Know! Anyone KNOW how I can Purchase these gems?

Play Episode

4min

Proactive - Interviews for investors

Nextech3D.ai partners with CSM.ai to revolutionize scalable 3D model creation

Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce a strategic partnership with CSM.ai, a leading team of AI researchers, product innovators, and digital artists. This collaboration aims to advance the creation of high-quality, cost-efficient 3D models at scale, providing businesses with next-generation product visualization technology. Nextech3D.ai and CSM.ai began working together in early 2025, successfully delivering hundreds of 3D models to customers with faster turnaround times and reduced costs. The partnership enhances Nextech3D.ai’s automated 3D modeling pipeline while leveraging CSM.ai’s deep AI expertise. At the same time, CSM.ai benefits from Nextech3D.ai’s extensive experience in 3D e-commerce applications. By combining resources, the companies aim to further scale production, drive down costs, and unlock new opportunities in the evolving 3D visualization industry, delivering substantial value to businesses and consumers alike. #nextech3d.al #otcqx #nexcf #cse #ntar #EvanGappelberg #AmazonSellerCentral #3DModeling #AIPhotography #EcommerceInnovation #3DTechnology #LifestylePhotography #ProactiveInterviews #TechInnovation #AmazonPartners#proactiveinvestors #nextech3d.al

Proactive - Interviews for investors

Atrato Capital on Supermarket Income REIT’s growth strategy; benefits of internalisation

Supermarket Income REIT PLC (LSE:SUPR, OTC:SUPIF) fund manager Robert Abraham and finance director Michael Perkins take Proactive's Stephen Gunnion through the company’s interim results for the six months to December 2024. Abraham highlighted the company’s strategic progress, including cost reductions through the proposed internalisation of its management team, asset disposals, and lease renewals. He noted that a recent disposal to Tesco demonstrated the value of these assets, selling at a 7% premium to book value. The lease renewals extended three short-term leases to 15 years at significantly higher rental rates, reflecting the strong demand for top-performing supermarket assets. Discussing financial benefits, Abraham explained that internalisation is expected to save the company £4 million annually, strengthening earnings and dividend cover. He also mentioned plans to explore a potential listing change to attract more investors and enhance capital access. Perkins outlined the financial performance, noting a 10% increase in net rental income to £58 million and a reduction in the upper cost ratio to 13.6%. Earnings per share rose by 3%, and the portfolio’s like-for-like valuation grew by 0.5% to £1.8 billion. The company’s loan-to-value ratio stands at 38%, ensuring financial flexibility for future strategic initiatives. Looking ahead, Abraham said Supermarket Income REIT will focus on completing the internalisation, exploring a listing change, and advancing strategic joint venture discussions. He also mentioned refinancing plans, considering long-dated bonds to align with the lease profile. Watch the full interview for more insights. For more videos, visit Proactive’s YouTube channel—don’t forget to like, subscribe, and enable notifications for future updates! #SupermarketREIT #AtratoCapital #RealEstateInvesting #CommercialProperty #DividendStocks #InvestmentNews #RetailInvesting #REIT #Tesco #StockMarket

Proactive - Interviews for investors

West Cobar Metals' high-grade copper discovery: Bulla Park delivers exceptional results

West Cobar Metals Ltd (ASX:WC1) managing director Matt Szwedzicki talked with Proactive's Jonathan Jackson about the company’s latest metallurgical results from the Bulla Park project. Early-stage testing has delivered high-grade copper, silver, and antimony concentrates with strong recoveries. Szwedzicki described the initial float test results as amazing. A key challenge at Bulla Park has been the presence of tetrahedrite, a less common mineral in Australia. However, recent testing has demonstrated successful separation and recovery processes. The company has now achieved 88% extraction of antimony, a commodity that has surged in value due to reduced exports from China. Szwedzicki also discussed West Cobar’s broader strategy, including plans to optimise metallurgical processes, assess a mineral resource estimate, and advance drilling at Bulla Park. Beyond this, the company is progressing its Salazar project in Western Australia, which holds rare earths, scandium, and alumina resources. The recent acquisition of the Mystique Gold Project further strengthens West Cobar’s portfolio, adding a promising gold exploration target. Stay tuned for more updates from West Cobar Metals. If you enjoyed this interview, give the video a like, subscribe to Proactive’s YouTube channel, and turn on notifications for the latest mining insights. #WestCobarMetals #Copper #Antimony #Mining #ASX #BullaPark #RareEarths #GoldExploration #Metals #Investing #Resources

Proactive - Interviews for investors

Clinical study SKNJCT-003 shows positive trends as company advances skin cancer research in UAE

Medicus Pharma CEO Dr. Raza Bokhari joined Steve Darling from Proactive to share updates on the ongoing SKNJCT-003 clinical study, which is being conducted at nine sites across the United States and aims to randomize 60 patients. An interim analysis conducted after enrolling more than half of the targeted participants has shown encouraging results. The study reports a clinical clearance rate exceeding 60%, with the investigational therapy demonstrating strong tolerability across both tested dosage levels. Notably, no dose-limiting toxicities (DLTs) or serious adverse events (SAEs) have been observed, and there have been no systemic effects or clinically significant abnormalities in laboratory results, ECGs, vital signs, or physical exams. These promising findings will be submitted to the U.S. Food and Drug Administration (FDA) as part of a Type C meeting request in Q2 2025. In parallel, the company is advancing its clinical initiatives for non-invasive basal cell carcinoma treatment with a newly proposed study. This randomized, double-blind, placebo-controlled, multi-center trial has been submitted for approval to the UAE Department of Health. The study aims to enroll up to 36 patients at prominent medical institutions, including Cleveland Clinic Abu Dhabi, Sheikh Shakbout Medical City, Burjeel Medical City, and the American Hospital of Dubai. Participants will be assigned in a 1:1:1 ratio to receive either a placebo or one of two dosage levels of the experimental treatment. This expansion into the UAE represents a significant step forward in the company’s mission to develop innovative, non-invasive therapies for skin cancer, broadening its global clinical footprint and reinforcing its commitment to advancing patient care. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #Biotech #CancerTreatment #ClinicalTrials #FDAApproval #SkinCancer #HealthcareInnovation #Investing #MedicalResearch

Followers	0
Posts	21
Boards Moderated	0
Alias Born	06/13/2021

Volume:	200,001
Day Range:	0.000001 - 0.000001
Bid:
Ask:
Last Trade Time:	12:22:09 PM EDT
Total Trades:	2

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

AEXE Detailed Quote

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Go Ad-Free